Buy Full Version
"MRI Compatible IV Infusion Pumps Market"

Let us help you !

Invalid Email.

Please Select Country.

Invalid contact no.

Special Symbols Not Allowed.

Invalid Security Code.

Thank You For Your Interest.

We've Successfully Got Your Message,

Our Executive will get back to you Shortly.

MRI Compatible IV Infusion Pumps Market by Product Type (Pumps and Tubing & Disposables) and End User (Hospitals, Ambulatory Surgical Centers, and Diagnostics & Imaging Centers) - Global Opportunity Analysis and Industry Forecast, 2019-2026

Medical Devices & Supplies	LI_184495	Pages: NA	Jan 2020 \| 1031 Views
Author(s) : NA	Tables: NA	Charts: NA	Formats*:

Infusion pumps are the medical devices that deliver fluids in particular doses into the patients body. These are employed to inject fluids such as nutrients and medications. MRI compatible IV infusion pumps provides safe and accurate delivery of intravenous fluids during and after an MRI scan.

Rise in prevalence of life threatening diseases, high demand of MRI diagnostics, growth in geriatric population, and increase in hospitalization of patients drive the market. However, factors such as high cost of devices and lack of awareness about the procedure restrain the market growth. The development of advanced IV infusion pump systems and untapped markets provide numerous opportunities for the market growth.

MRI compatible IV infusion pumps market is segmented on the basis of product type, end user, and region. On the basis of product type, the market is bifurcated into pumps, and tubing & disposables. Pumps can be further sub-segmented into infusion and IV pumps. Infusion pumps can be segmented as, magnetic and non-magnetic pump system and IV pumps as peristal IV pumps, and piston driven pumps. Based on end user, the market is divided into hospitals, ambulatory surgical centers, and diagnostics & imaging centers. By geography, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in this market include B. Braun Melsungen AG, IRadimed Corporation, Arcomed AG, Fresenius SE & Co. KGaA, Becton, Dickinson and Company, Baxter International Inc., Medtronic Plc., Smiths Group plc, F. Hoffmann-La Roche AG, and Kimberly-Clark Health Care.

Key Benefits

The study provides an in-depth analysis of the global MRI compatible IV infusion pumps market with current trends and future estimations to elucidate the imminent investment pockets.
The report provides information about the current and upcoming trends in the market from 2016 to 2023, which helps to determine the prevailing opportunities.
Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale are provided.
Key market players are profiled and their strategies are analyzed thoroughly, which elucidate the competitive outlook of the market.

MRICompatible Iv Infusion Pumps Market Key Segments:

By Product Type

Pumps
- Infusion Pumps
  - Magnetic Pumps
  - Non-Magnetic Pumps
- IV Pumps
  - Peristal IV Pumps
  - Piston Driven Pumps
Tubing and Disposables

By End User

Hospitals
Ambulatory Surgical Centers (ASCs)
Diagnostics and Imaging Centers

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

CHAPTER 4 MRI COMPATIBLE IV INFUSION PUMPS MARKET, BY PRODUCT TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. PUMPS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Infusion Pumps

4.2.4.1. Market size and forecast
4.2.4.2. Magnetic Pumps

4.2.4.2.1. Market size and forecast

4.2.4.3. Non-Magnetic Pumps

4.2.4.3.1. Market size and forecast

4.2.5. IV Pumps

4.2.5.1. Market size and forecast
4.2.5.2. Peristal IV Pumps

4.2.5.2.1. Market size and forecast

4.2.5.3. Piston Driven Pumps

4.2.5.3.1. Market size and forecast

4.3. TUBING AND DISPOSABLES

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

CHAPTER 5 MRI COMPATIBLE IV INFUSION PUMPS MARKET, BY END USER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. HOSPITALS

5.2.1. Market size and forecast

5.3. AMBULATORY SURGICAL CENTERS

5.3.1. Market size and forecast

5.4. DIAGNOSTICS AND IMAGING CENTERS

5.4.1. Market size and forecast

CHAPTER 6 MRI COMPATIBLE IV INFUSION PUMPS MARKET, BY REGION

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast

6.2.4. North America MRI Compatible IV Infusion Pumps Market by Product Type
6.2.5. North America MRI Compatible IV Infusion Pumps Market by End User

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast

6.3.4. Europe MRI Compatible IV Infusion Pumps Market by Product Type
6.3.5. Europe MRI Compatible IV Infusion Pumps Market by End User

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. South Korea market size and forecast
6.4.3.6. Rest of Asia-Pacific market size and forecast

6.4.4. Asia-Pacific MRI Compatible IV Infusion Pumps Market by Product Type
6.4.5. Asia-Pacific MRI Compatible IV Infusion Pumps Market by End User

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. Brazil market size and forecast
6.5.3.2. Saudi Arabia market size and forecast
6.5.3.3. South Africa market size and forecast
6.5.3.4. Rest of LAMEA market size and forecast

6.5.4. LAMEA MRI Compatible IV Infusion Pumps Market by Product Type
6.5.5. LAMEA MRI Compatible IV Infusion Pumps Market by End User

CHAPTER 7 COMPANY PROFILES

7.1. B. BRAUN MELSUNGEN AG

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. IRADIMED CORPORATION

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. ARCOMED AG

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. FRESENIUS SE & CO. KGAA

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. BECTON, DICKINSON AND COMPANY

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

7.6. BAXTER INTERNATIONAL INC.

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments

7.7. MEDTRONIC PLC.

7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. SMITHS GROUP PLC

7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments

7.9. F. HOFFMANN-LA ROCHE AG

7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments

7.10. KIMBERLY-CLARK HEALTH CARE

7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Online Only ~~$3,456~~ $3,041 Data Pack/Excel ~~$3,840~~ $3,379 Single User License ~~$5,370~~ $4,726 Five User License ~~$6,450~~ $5,676 Enterprise User License ~~$8,995~~ $7,916

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com